Hugh Paul ONeill - 01 Jan 2026 Form 4 Insider Report for Keenova Therapeutics plc

Reporting relationship: EVP, Qual & Ops, Spec Brands
Issuer ticker: N/A
Reported as of: 01 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 18:03:47 UTC
Prior SEC filing: 04 Aug 2025
Next SEC filing: 26 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Tyndall, Attorney-in-Fact

Key filing fact

Hugh Paul ONeill filed Form 4 for Keenova Therapeutics plc on 05 Jan 2026.

Key facts

This page summarizes Hugh Paul ONeill's Form 4 filing for Keenova Therapeutics plc.
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2026, 18:03.

Change

Previous filing in this sequence was filed on 04 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002015073 Primary reporting owner

ONeill Hugh Paul

Relationship: EVP, Qual & Ops, Spec Brands
Address: 440 ROUTE 22 EAST, SUITE 302, BRIDGEWATER
Signature: /s/ Mark Tyndall, Attorney-in-Fact
Signature date: 05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +2,055
Change %: +251%
Price
Shares after: 2,875
Date: 01 Jan 2026
Ownership: Direct
Footnotes: F1

No ticker transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -1,073
Change %: -37%
Price
Shares after: 1,802
Date: 01 Jan 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,055
Change %: -12%
Price: $0.000000
Shares after: 14,385
Date: 01 Jan 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,055
Exercise price
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.

Footnote F2

The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.

Footnote F3

On February 2, 2024, the Reporting Person was granted 5,129 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 4 below.

Footnote F4

Reflects that the Reporting Person received 2,761 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. ("Par Health") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health.

SEC remarks

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.